BR112017014412A2 - ?método para melhorar a saúde de um mamífero feminino e/ou aumentar a produção de leite e/ou aumentar o teor de gordura do leite produzido pelo mamífero, leite, produto lácteo para consumo humano, kit, e, artigo de fabricação? - Google Patents

?método para melhorar a saúde de um mamífero feminino e/ou aumentar a produção de leite e/ou aumentar o teor de gordura do leite produzido pelo mamífero, leite, produto lácteo para consumo humano, kit, e, artigo de fabricação?

Info

Publication number
BR112017014412A2
BR112017014412A2 BR112017014412A BR112017014412A BR112017014412A2 BR 112017014412 A2 BR112017014412 A2 BR 112017014412A2 BR 112017014412 A BR112017014412 A BR 112017014412A BR 112017014412 A BR112017014412 A BR 112017014412A BR 112017014412 A2 BR112017014412 A2 BR 112017014412A2
Authority
BR
Brazil
Prior art keywords
milk
mammal
increasing
fat content
health
Prior art date
Application number
BR112017014412A
Other languages
English (en)
Inventor
Carvalho Bicalho Rodrigo
Original Assignee
Univ Cornell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cornell filed Critical Univ Cornell
Publication of BR112017014412A2 publication Critical patent/BR112017014412A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2053—IL-8
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C2230/00—Aspects relating to animal feed or genotype
    • A23C2230/10—Animal milk with modified composition due to a specific feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Peptides Or Proteins (AREA)

Abstract

a presente descrição provê composições e métodos para melhorar a saúde reprodutiva dos mamíferos e aumentar a produção de leite de mamíferos fêmeas. os métodos envolvem a administração de uma quantidade eficaz de il-8 a um mamífero fêmea, de modo que a saúde reprodutiva do mamífero seja melhorada, ou a produção de leite do mamífero seja aumentada ou o teor de gordura do leite seja aumentado. em outro aspecto, a descrição inclui profilaxia e/ou terapia de condições uterinas através da administração de il-8 a um mamífero feminino.
BR112017014412A 2015-01-05 2016-01-05 ?método para melhorar a saúde de um mamífero feminino e/ou aumentar a produção de leite e/ou aumentar o teor de gordura do leite produzido pelo mamífero, leite, produto lácteo para consumo humano, kit, e, artigo de fabricação? BR112017014412A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562099643P 2015-01-05 2015-01-05
PCT/US2016/012154 WO2016111992A1 (en) 2015-01-05 2016-01-05 Compositions and methods using il-8 to improve milk production and reproductive health in mammals

Publications (1)

Publication Number Publication Date
BR112017014412A2 true BR112017014412A2 (pt) 2018-05-15

Family

ID=56356347

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017014412A BR112017014412A2 (pt) 2015-01-05 2016-01-05 ?método para melhorar a saúde de um mamífero feminino e/ou aumentar a produção de leite e/ou aumentar o teor de gordura do leite produzido pelo mamífero, leite, produto lácteo para consumo humano, kit, e, artigo de fabricação?

Country Status (12)

Country Link
US (2) US10500253B2 (pt)
EP (1) EP3242675B1 (pt)
JP (1) JP6799543B2 (pt)
CN (1) CN107427555B (pt)
AU (1) AU2016205456B2 (pt)
BR (1) BR112017014412A2 (pt)
CA (1) CA2972957A1 (pt)
CO (1) CO2017007689A2 (pt)
ES (1) ES2939300T3 (pt)
MX (1) MX2017008881A (pt)
RU (1) RU2682318C2 (pt)
WO (1) WO2016111992A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11071747B2 (en) 2016-11-29 2021-07-27 University Of Iowa Research Foundation Use of NAD precursors for breast enhancement
JP7136795B2 (ja) * 2016-11-29 2022-09-13 ユニバーシティー オブ アイオワ リサーチ ファウンデーション 母体の健康および／または子の健康を向上させるためのｎａｄ前駆体の使用
WO2023239345A1 (en) * 2022-06-06 2023-12-14 Hydrogreen, Inc. Hydroponically sprouted cereal grains as a mechanism for fertility improvement and increased conception rates, feed efficiency, and postpartum energy in ruminants

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3108875A (en) * 1962-03-22 1963-10-29 Raymond W Bell Process for producing sweetened condensed cream
GB9124775D0 (en) * 1991-11-21 1992-01-15 Medical Res Council Cervical ripening
EP0754946A4 (en) 1994-04-08 1997-07-09 Daiichi Pure Chemicals Co Ltd METHOD FOR DIFFERENTIATING VAGINAL SECRETION OR CERVICAL SLIME FROM PREGNANT WITH A SUSPECT OF A THREATENING FAILURE
EP0790061A1 (en) 1995-08-28 1997-08-20 Toray Industries, Inc. Fertility agent
DE19548630A1 (de) 1995-12-12 1997-06-19 Schering Ag Verfahren zur Reinigung von rekombinantem Human-Interleukin - 8
CN1225016A (zh) * 1996-07-05 1999-08-04 维罗塞尔公司 一种抗病毒和抗肿瘤药－白细胞介素－8
ES2216447T3 (es) 1998-08-17 2004-10-16 Pfizer Products Inc. Composiciones proteicas estabilizadas.
US20060233748A1 (en) 2002-09-13 2006-10-19 Ahmed Merzouk Mimetics of interleukin-8 and methods of using them in the prevention, treatment, diagnosis, and ameliorization of symptoms of a disease
GB0103354D0 (en) 2001-02-10 2001-03-28 Medical Res Council Biologically active agents
EP1958637A1 (en) 2007-02-14 2008-08-20 Revotar Biopharmaceuticals AG Pharmaceutical composition for the treatment of IL-8 mediated diseases
US8920814B2 (en) * 2007-03-08 2014-12-30 The Governors Of The University Of Alberta Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections
AU2008236622B2 (en) 2007-04-09 2013-01-10 Wake Forest University Health Sciences Oxygen-generating compositions for enhancing cell and tissue survival in vivo
CN101253934B (zh) * 2008-04-07 2013-07-24 中国农业科学院北京畜牧兽医研究所 奶牛饲料用复合微生物添加剂及其制备方法
RU2405376C2 (ru) 2009-02-03 2010-12-10 Государственное учреждение Волгоградский научно-исследовательский технологический институт мясо-молочного скотоводства и переработки продукции животноводства Россельхозакадемии (ГУ ВНИТИ ММС и ППЖ Россельхозакадемии) Премикс для лактирующих коров
WO2012158736A1 (en) * 2011-05-17 2012-11-22 modeRNA Therapeutics Engineered nucleic acids and methods of use thereof for non-human vertebrates
RU2521367C2 (ru) 2012-07-04 2014-06-27 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения и социального развития Российской Федерации Способ прогнозирования развития плацентарной недостаточности
EP2810695A1 (en) * 2013-06-06 2014-12-10 Ceva Sante Animale Compositions and Method for controlling infections in non-human mammals using acute phase proteins

Also Published As

Publication number Publication date
CN107427555A (zh) 2017-12-01
RU2017127776A (ru) 2019-02-08
MX2017008881A (es) 2017-11-13
AU2016205456A1 (en) 2017-08-17
EP3242675A1 (en) 2017-11-15
ES2939300T3 (es) 2023-04-20
US20200046803A1 (en) 2020-02-13
US10500253B2 (en) 2019-12-10
EP3242675B1 (en) 2022-11-30
JP2018502916A (ja) 2018-02-01
AU2016205456B2 (en) 2021-10-07
EP3242675A4 (en) 2019-03-20
US11406689B2 (en) 2022-08-09
WO2016111992A1 (en) 2016-07-14
US20180028615A1 (en) 2018-02-01
JP6799543B2 (ja) 2020-12-16
CO2017007689A2 (es) 2018-01-31
RU2017127776A3 (pt) 2019-02-08
CN107427555B (zh) 2021-09-14
RU2682318C2 (ru) 2019-03-19
CA2972957A1 (en) 2016-07-14

Similar Documents

Publication Publication Date Title
CY1120314T1 (el) Ζωοτροφη και μια διαδικασια για την παρασκευη της
BR112016029906A2 (pt) compostos excipientes redutores de viscosidade para formulações proteicas
CO2019006292A2 (es) Composiciones de aminoácidos y métodos para el tratamiento de enfermedades y trastornos musculares
BR112013027554A2 (pt) "usos de compostos no tratamento de mal de alzheimer, doença de huntington, autismo e outros distúrbios"
BR112016021648A2 (pt) novos compostos
EA201890767A1 (ru) C4-модифицированные производные олеаноловой кислоты для ингибирования il-17 и других применений
BR112016019825A2 (pt) anticorpos do fator bb do complemento
UY36868A (es) Composiciones para tratamiento de enfermedades mediadas por interleuquina 5 (il-5)
BR112017012682A2 (pt) processo para aperfeiçoamento de porções de músculo e produtos
BR112015011931A2 (pt) composições nutricionais contendo treonato de magnésio e usos das mesmas
AR097149A1 (es) Método para suministrar una composición alimenticia a rumiantes
BR112016006649A2 (pt) biscoito macio com glicose de liberação lenta
BR112017014412A2 (pt) ?método para melhorar a saúde de um mamífero feminino e/ou aumentar a produção de leite e/ou aumentar o teor de gordura do leite produzido pelo mamífero, leite, produto lácteo para consumo humano, kit, e, artigo de fabricação?
BR112016011472A2 (pt) tienopirimidinas como inibidores de mknk1 e mknk2
BR112016011489A2 (pt) composição nutricional pediátrica com peptídeos do leite para crescimento e desenvolvimento saudável
MA38925A1 (fr) Dérivés de phénylalanine substitués
BR112018014467A2 (pt) tecnologia de sinergismo fármaco-anticorpo para o tratamento de doenças
BR112019022912A2 (pt) Métodos e composições para tratar doenças oculares alérgicas
BR112017007066A2 (pt) composições e métodos para melhorar a mobilidade ou a atividade, ou tratar a debilidade
BR112016021656A2 (pt) inibidores das vias de sinalização de wnt
BR112015018421A2 (pt) composição nutricional anti-regurgitação
BR112014017225A2 (pt) uso de sistemas de carboidrato específicos durante gravidez para efetuar os descendentes
BR112015030645A2 (pt) composição, processo e kit para processamento de açúcar
BR112017013650A2 (pt) processo e concentrado para a fabricação de uma pré-mistura
BR112015001694A2 (pt) uso de uma composição para a fabricação de um medicamento para tratamento de distúrbios cutâneos e/ou distúrbios de proliferação celular anormal; composição; e método para preparar uma composição farmacêutica

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]